1. Home
  2. SCLX vs STEM Comparison

SCLX vs STEM Comparison

Compare SCLX & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$17.70

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Logo Stem Inc.

STEM

Stem Inc.

HOLD

Current Price

$17.62

Market Cap

120.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
STEM
Founded
2011
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
120.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
STEM
Price
$17.70
$17.62
Analyst Decision
Hold
Hold
Analyst Count
1
5
Target Price
N/A
$14.60
AVG Volume (30 Days)
119.6K
177.3K
Earning Date
11-14-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$164,948,000.00
Revenue This Year
N/A
$3.43
Revenue Next Year
$749.70
$12.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$5.81
52 Week High
$34.27
$33.60

Technical Indicators

Market Signals
Indicator
SCLX
STEM
Relative Strength Index (RSI) 44.92 50.49
Support Level $18.34 $16.57
Resistance Level $20.62 $19.34
Average True Range (ATR) 2.14 1.32
MACD -0.28 0.40
Stochastic Oscillator 1.86 74.79

Price Performance

Historical Comparison
SCLX
STEM

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

Share on Social Networks: